Background {#Sec1}
==========

Acute mountain sickness (AMS) may occur when a person who is used to being at a low altitude ascends to a higher altitude \[[@CR1]\]. The typical symptoms include headache, anorexia, nausea, vomiting, dyspnoea, lassitude, and insomnia after arriving at a high altitude. This condition is termed AMS. It is a clinical syndrome in which the body decompensates in response to acute hypoxic conditions \[[@CR2]--[@CR4]\]; AMS is exacerbated by exercise and can be disabling \[[@CR5]\]. More seriously, if symptoms are ignored, AMS can develop into life-threatening high-altitude cerebral edema \[[@CR6]\]. The individual susceptibility, ascending velocity, time spent at altitude, activity levels and altitude reached may be the common causes of AMS \[[@CR7]\]; men and women present with different AMS morbidity profiles. Previous studies that reported sex as a risk factor for AMS were inconsistent, although some indicated that women are more likely to suffer from AMS than men. For example, in Murdoch's report, the prevalence of AMS was 88.6% vs 69.0% (women vs. men, respectively) \[[@CR4]\], and rates of 60.0% vs. 21.9% (women vs. men, respectively) were reported in the study by other authors \[[@CR8]\], while other studies showed a higher prevalence in men \[[@CR9], [@CR10]\] or no sex-based difference \[[@CR11], [@CR12]\]. Although it has been suggested that sex-based differences in the prevalence of AMS patients exist, to date, no systematic review or meta-analysis has addressed this issue.

The perspective in the existing literature is that the differences between men and women are mainly determined by the physical differences and the different hormone levels \[[@CR13], [@CR14]\]. Some investigators believe that the differences in the prevalence of AMS between men and women is also affected by hormones or other factors associated with hormones \[[@CR15]\]. However, that is only hypothesis, and the pathophysiological mechanism of AMS is still not entirely clear. To determine whether there are sex-based differences in the prevalence of AMS, we conducted a systematic literature review of studies using the same criteria and performed a meta-analysis to quantify the results.

Methods {#Sec2}
=======

This review was conducted according to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-analyses) guidelines \[[@CR16]\].

Search strategy {#Sec3}
---------------

Searches were conducted in PubMed, EMBASE and Web of Science for articles published before August 2019. The search strings included terms pertaining to: 1) AMS (such as, acute mountain sickness, acute high altitude disease, acute mountain illness, altitude disease, Lake Louise Scoring System (LLSS)); 2) epidemiological indicators of disease (such as, prevalence, incidence, risk, epidemiology); and 3) subjects characteristics (such as, sex, gender), using the logical connectives "OR" and "AND" to combine them. The titles and abstracts of the returned articles were searched for the relevant variables, and the initial eliminations were made. The publication dates were limited to article published after 1991 because the LLSS was first propounded in February, 1991 \[[@CR17]\]. The language was restricted to English. Furthermore, the studies listed in the references of the articles were reviewed.

Study selection {#Sec4}
---------------

Two authors, YPH and JLW, independently reviewed the publications. We first applied Endnote X9 software to eliminate duplicate publications, and read the titles and abstracts to initially select candidate articles. For those publications that were not clearly described, we screened them by downloading and reading the full texts, and discrepancies were resolved by consensus. The eligible studies met the following criteria:

1\) The studies were limited to prospective studies with high reliability and sufficient data. Clinical research, interventional experiments or retrospective studies were excluded due to the possibility of selection bias.

2\) In terms of the diagnostic criteria, the included studies adopted the same data collection technology, used the LLSS \[[@CR17]\], and applied the same two cut-off values (LLSS ≥3 or ≥ 4) to define AMS. Studies using other diagnostic criteria were excluded from the pooled analysis because diverse criteria may result in different prevalence, affecting the sex-based differences.

3\) The studies included sex-specific numbers or rates, or the data needed to calculate the same, i.e., the prevalence or percentages of men and women with AMS.

4\) The average age of the subjects was over 18 years, as younger subjects are not sufficiently physically mature to enable the assessment of sex-based effects.

5\) The minimum altitude was 2500 m. This height can cause physical changes, such as acute altitude sickness, high altitude pulmonary edema and other diseases.

Data extraction {#Sec5}
---------------

The data extraction table was developed by YPH and JLW. Disagreements were reconciled through consensus in face-to-face meetings, and consensus was reached after discussion.

The information extracted from each study included the first author, publication year, location, average age, race, participant type, altitude, cut-off value for the LLSS to identify AMS, and number of women or men with AMS or the AMS prevalence rates.

Assessment of AMS {#Sec6}
-----------------

The methods for the assessment of AMS include the LLSS, the Environmental Symptoms Questionnaire III (ESQ-III) and so on \[[@CR18], [@CR19]\]. All of these methods are widely utilized in studies of the effects of altitude, but there is still no golden standard and the methods for the assessment of AMS depend on subjective symptoms. Some articles have compared the LLSS with the ESQ-III AMS score, subjects are likely to receive a different AMS diagnosis when evaluated by different scoring systems \[[@CR20], [@CR21]\]. Despite that, this meta-analysis was performed based on the LLSS. This criterion aimed to reduce the confounding factors introduced by means of different evaluation methods and improve the quality of the assessment. Scores in the LLSS range from 0 to 12, and a total score ≥ 3 in the presence of a headache was the diagnostic criterion for AMS. However, some researchers used 4 points as a cut-off value to diagnose AMS \[[@CR22], [@CR23]\]. We therefore concluded that a subgroup analysis was needed to evaluate the implications of the different cut-off values.

Quality assessment {#Sec7}
------------------

The methodological quality of each study using LLSS as assessed based on the tool developed by Loney et al. \[[@CR24]\], which aimed to critically appraise research articles that estimate the prevalence or incidence of a disease. Two authors (YPH and JLW) independently implemented this method, with all disagreements resolved by consensus. The scoring system is an 8-point scale consisting of three parts: validity of research methods (0--6 points), interpretation of the results (0--1 point) and applicability of the results (0--1 point). Detailed scores for each study can be found in [Appendix](#Sec19){ref-type="sec"}. A total score of 4 or 5 is considered adequate quality, and a score ≥ 6 points is defined as high quality. However, for publications with a score ≤ 3 were excluded to ensure that the included studies had adequate reliability and methodological quality.

Statistical analysis {#Sec8}
--------------------

The meta-analysis was performed using Stata 14.1 (Stata Corp, College Station, TX, USA). We used a random-effects model to aggregate the data because the random-effects model is more conservative than the fixed-effect model; in addition, it allows for the existence of heterogeneity. Relative risks (*RR*) were used to assess the binary outcomes variables rather than odds ratios (*OR*), as the RR are easier to explain and do not overestimate the magnitude of the effect \[[@CR25]\]. Heterogeneity among studies was tested using the I2 statistic. Meta-regression analysis and subgroup analysis were used to verify the source of the heterogeneity. Egger's test, Begg's test and meta-funnel plot asymmetry were used to test for the presence of publication bias \[[@CR26]\]. There is a significant difference if *P* \< 0.05.

Results {#Sec9}
=======

Search results {#Sec10}
--------------

A total of 1718 publications relevant to AMS were identified in the databases. Additionally, 4 additional records were identified through other sources. The abstracts of 974 were reviewed, of which 80 articles were reviewed in full, and 18 were ultimately included. The excluded studies were thirty-one with no sex-based data reported or specific numbers, eight that were not in English, six that were not prospective studies, fourteen with no sex differences, nine with average ages \< 18 years, two without full-text versions available and one without a response from the authors regarding requested data. Therefore, a total of 18 full-text articles were included in this meta-analysis (Table [1](#Tab1){ref-type="table"}), and the selection flow chart is shown in Fig. [1](#Fig1){ref-type="fig"}. Table 1Details of eligible AMS-related studies that were included in the meta-analysisReferencesLocationRace of subjectsSubjectsDiagnostic criteriaAverage age (years)Altitude (m)Total subjects (*n*)Prevalence (%)TotalWomenMenMurdoch et al. (1995) \[[@CR4]\]Shyangboche, AsiaAsianGuestsLLSS ≥345.3374015477.9 (120/154)88.6 (62/70)69.0 (58/84)Ziaee et al. (2003) \[[@CR9]\]Mount Damavand, AsiaAsianHikersLLSS ≥331.9420045960.8 (279/459)58.1 (86/148)63.1 (196/311)Wagner et al. (2008) \[[@CR10]\]Mt. Whitney, North AmericaAmericanHikersLLSS ≥337.6441988642.6 (337/886)37.7 (80/212)44.1 (297/674)Jafarian et al. (2008) \[[@CR27]\]Tehran, AsiaAsianVolunteersLLSS ≥328.834509037.8 (34/90)53.3 (16/30)30.0 (18/60)Mairer et al. (2009) \[[@CR22]\]Austrian Alps, EuropeEuropeanHikersLLSS ≥437.42200--350042216.6 (70/422)18.9 (20/106)15.8 (50/316)Wu et al. (2010) \[[@CR28]\]Lhasa, AsiaAsianPassengersLLSS ≥340.42600--507222227.0 (60/222)34.5 (30/87)22.2 (30/135)Wang et al. (2010) \[[@CR11]\]Jade Mountain, AsiaAsianHikersLLSS ≥340.23925106636.0 (384/1066)36.3 (128/353)35.9 (256/713)Mairer et al. (2010) \[[@CR29]\]Alps, EuropeEuropeanMountaineersLLSS ≥434.7(group 1)36.8(group 2)3454 and 381715537.4 (58/155)39.3 (11/28)37.0 (47/127)Modesti et al. (2011) \[[@CR8]\]Mount EverestBase Camp, AsiaAsianVolunteersLLSS ≥44054004734.0 (16/47)60.0 (9/15)21.9 (7/32)Chen et al. (2012) \[[@CR23]\]Jade Mountain, AsiaAsianHikersLLSS ≥4423402--395278732.8 (258/787)34.7 (92/265)31.8 (166/522)Maclnnis et al. (2013) \[[@CR30]\]Gosainkunda,AsiaAsianPilgrimsLLSS ≥336.7438049134.0 (167/491)45.5 (67/147)29.1 (100/344)Mandolesi et al. (2014) \[[@CR31]\]Mount Rosa, EuropeEuropeanMountaineersLLSS ≥336.43647--45596040.0 (24/60)54.5 (6/11)36.7 (18/49)Hsu et al. (2015) \[[@CR32]\]Jiaming Lake,AsiaAsianMountaineersLLSS ≥319.835509120.9 (19/91)14.3 (4/28)23.8 (15/63)Ren et al.(2015) \[[@CR33]\]Lhasa, AsiaAsianVolunteersLLSS ≥438.43100--43008043.8 (35/80)53.1 (26/49)29.0 (9/31)Horiuchi et al. (2016) \[[@CR34]\]Mount Fuji,AsiaAsianClimbersLLSS ≥336.1377634529.5 (98/345)32.6 (46/141)25.5 (52/204)Sánchez-Mascuñano et al. (2017) \[[@CR35]\]Spain, EuropeEuropeanTravellersLLSS ≥337.7\> 340030225.8 (78/302)39.0 (53/156)17.1 (25/146)Horiuchi et al. (2018) \[[@CR12]\]Mount Fuji,AsiaAsianClimbersLLSS ≥337.4\> 2870193231.6 (610/1932)32.9 (252/767)30.7 (358/1165)J. Boos et al. (2018) \[[@CR36]\]Himalayas,AsiaAsianMilitary servicemenLLSS ≥332.151408047.5 (38/80)69.2 (18/26)37.0% (20/54)*AMS* acute mountain sickness, *LLSS* Lake Louise Scoring System Fig. 1Flow chart of the study selection process. The flowchart describes the process of searching for and screening of eligible studies on AMS

Selected studies and characteristics {#Sec11}
------------------------------------

A total of 18 studies \[[@CR4], [@CR8]--[@CR12], [@CR22], [@CR23], [@CR27]--[@CR36]\] on AMS using LLSS were included in this analysis, and the detailed information is shown in Table [1](#Tab1){ref-type="table"}. The publication period ranged from 1995 to 2018, with the majority of the publication dates being after 2000. The experimental subjects included guests, pilgrims, hikers, volunteers, and mountaineers. The study altitudes ranged from 2200 m to 5400 m, but the altitude in most studies was above 2500 m. The number of subjects was between 47 and 1932, and the total number included in the analysis was 7669. The highest overall prevalence of AMS was 77.9%, and the lowest was 16.6% \[[@CR4], [@CR22]\]. The maximal single-study prevalence rates for AMS in women and men were 88.6 and 69.0%, respectively, whereas the minimal values in women and men were 14.3 and 15.8%, respectively \[[@CR4], [@CR22], [@CR32]\]. Fifteen studies reported that women had a higher prevalence of AMS than men in the same experiment. It should be noted that all of the studies used the LLSS for the diagnosis of AMS, but 4 of them defined the diagnostic criterion as an LLSS value of at least 4 with headache present, whereas the remaining 15 studies defined the criterion as an LLSS score of at least 3 with headache present. In selecting the studies, some studies were excluded on the basis of ambiguous data regarding the number of subjects or the prevalence despite demonstrating a sex-based distinction \[[@CR37]\].

Quality assessment {#Sec12}
------------------

The details of the quality assessment of the included studies are listed in [Appendix](#Sec19){ref-type="sec"}; 4 studies were rated "high quality" (22.2%, total score ≥ 6), 14 studies were considered "good quality" (77.8%; total score = 4 to 5), and there was one thesis rated "low quality" (total score ≤ 3). The limitations affecting the quality of the studies were generally the following: small sample size (10 of 18 studies), refusal to participate not described (16 of 18 studies), biased assessors (17 of 18 studies) and 95% confidence intervals not provided (13 of 18 studies). To ensure the reliability of the included studies, we excluded low-quality studies, and 18 studies were included in the final meta-analysis.

Meta-analysis results of sex-based difference in AMS {#Sec13}
----------------------------------------------------

We selected a fixed-effects model for the initial stage of the analysis, but the heterogeneity did not meet the condition for this model (Tau^2^ = 0.0403, Chi^2^ = 50.15, *df* = 17; *I*^2^ = 66.1%, *P* = 0.000). We therefore chose a random-effects model for the final evaluation of the data. The results showed that there was a statistically significant higher prevalence of AMS in women than in men (*RR* = 1.24, 95% CI 1.09--1.41). The *RR* values for the individual studies and the pooled estimate are shown in Fig. [2](#Fig2){ref-type="fig"}. Fig. 2Forest plot of the 18 AMS studies in the random-effects model. Summaries of the men and women results for the risk of AMS are displayed. The risk factors are indicated based on the relative risk for women with regard to the prevalence of AMS.Heterogeneity: Tau^2^ = 0.0403, Chi^2^ = 50.15, *df* = 17; *I*^2^ = 66.1%, *P* = 0.000. Test for overall effect: *Z* = 3.29, *P* = 0.001. *RR*: relative risk; 95% CI: 95% confidence interval

Meta-regression analysis {#Sec14}
------------------------

The heterogeneity was significant in the analysis (*I*^2^ = 66.1%, *P* = 0.000), so we performed the meta-regression analysis to explore the contribution of the four covariates (race, age, LLSS cut-off value and number of subjects) in the heterogeneity. The results indicated that the number of subjects was a possible contributor to the heterogeneity (coefficient = − 2.17, *P* = 0.049). The contributions of race, LLSS cut-off value and age were not obvious (*P* = 0.826, *P* = 0.901, *P* = 0.970, respectively, Table [2](#Tab2){ref-type="table"}). Table 2Covariates in the meta-regression analysis of AMS studiesHeterogeneous factorsCoefficientStandard error*tP* Race of subjects−0.04152750.1847339−0.220.826 Number of subjects−0.35645540.1640766−2.170.049 LLSS cut-off value−0.02235830.1768234−0.130.901 Average age0.00687260.17744870.040.970 Constant0.89832180.49448991.820.092*LLSS* Lake Louise Scoring System

Subgroup analysis {#Sec15}
-----------------

The result of the regression analysis showed that different numbers of subjects (*n* \< 300 vs. *n* ≥ 300) was the main cause of the heterogeneity, and the heterogeneity was improved after the subgroup analysis (*I*^2^ = 24.6%, *P* = 0.225). The evaluation of the effect of the number of subjects showed that the studies with small sample sizes had a higher rate of AMS (*RR* = 1.60, 95% CI 1.27--2.00) compared with those that with larger sample sizes (*RR* = 1.12, 95% CI 0.98--1.28).

Three other subgroups (race, age, LLSS cut-off value) were analyzed in the context of the overall estimate by means of different stratifications. Subgroup analyses were performed to determine whether sex-based differences emerged in subgroups stratified by race, but the researchers found no statistically significant differences between Asian and non-Asian populations (*RR* = 1.27 vs. *RR* = 1.16), indicating that people of different races have similar susceptibilities to AMS.

Moreover, the results for other subgroups showed that there was no evidence that sex-based differences were affected by age (average age \< 40 years vs. ≥40 years) or LLSS cut-off value (LLSS ≥3 vs. ≥4), and all subgroup analysis data are shown in Table [3](#Tab3){ref-type="table"}. Table 3The heterogeneity of the subgroup analysis of the included AMS studiesSubgroupSubjects numberAMS \[*n*(%)\]*RR* (95%CI)*P*WomenMenWomenMenAll participants263950301006(38.1)1722(34.2)1.24(1.09--1.41)0.000Race Aisan21263718836(39.3)1285(34.6)1.27(1.10--1.48)0.000 No-Aisan5131312170(33.1)437(33.3)1.16(1.09--1.41)0.005Number of subjects \<300344635182(52.9)222(35.0)1.60(1.27--2.00)0.225  ≥ 30022954385824(35.9)1500(34.2)1.12(0.98--1.28)0.001LLSS cut-off value  ≥ 321764002848(39.0)1443(36.1)1.25(1.08--1.45)0.000  ≥ 44631028158(34.1)279(27.1)1.27(1.01--1.60)0.168Average age \<40 years18493544685(37.0)1205(34.0)1.32(1.02--1.71)0.000  ≥ 40 years7901486321(40.6)517(34.8)1.22(1.04--1.44)0.013*LLSS* Lake Louise Scoring System, *AMS* acute mountain sickness; *RR* relative risk, *95% CI* 95% confidence interval

Publication bias {#Sec16}
----------------

Publication bias was assessed with meta-funnel plots (Fig. [3](#Fig3){ref-type="fig"}), Egger's test and Begg's test. The results showed that there was no evidence of significant publication bias in the combined studies on the basis of Egger's test (bias coefficient = 1.48, *P* = 0.052) and Begg's test (*P* = 0.130). Fig. 3Funnel plot of the 18 AMS studies to assess publication b.ias. Note the symmetrical distribution of the studies. In addition, all studies were combined and subjected to Egger's test (bias coefficient = 1.48, *P* = 0.052) and Begg's test (*P* = 0.130). LogRR: log relative risk; SE (LogRR): standard error of the log relative risk

Discussion {#Sec17}
==========

The main purpose of this meta-analysis was to evaluate whether there is a difference between women and men in terms of their susceptibility to AMS using LLSS. After excluding the studies that did not meet the screening criteria, a total of 18 studies were included in this systematic meta-analysis. The results showed that the prevalence of AMS is approximately 1.24 times greater in women than in men, regardless of age or race, however, we could not exclude studies where patients were on acetazolamide. Although no previous systematic evaluation or meta-analysis has shown that AMS has obvious sex-based differences, most of studies are consistent with the results of this meta-analysis (total 15/18); for example, MacInnis et al. \[[@CR30]\] reported that the prevalence in women was 45.5%, which was 12.5% higher than the prevalence in men, indicating that women were more likely than men to suffer from AMS (45.5% vs 34.0%, *RR* = 1.62). In contrast, there have been reports that men are more likely than women to suffer from AMS \[[@CR9], [@CR10]\].

Many mechanisms can explain the relatively high prevalence in women. One hypothesis regarding the pathogenesis is intracranial hypertension \[[@CR38], [@CR39]\]. Two factors contributing to increased intracranial pressure need attention: vascular permeability and fluid retention. Oestrogen is thought to upregulate vascular endothelial growth factor (VEGF) expression \[[@CR40]\]. VEGF is responsible for the augmentation of vascular leakage \[[@CR41]\], which increases the exudation of tissue fluid and causes intracranial hypertension. Another factor is related to fluid retention. In an early study, the subjects that developed severe AMS displayed water retention within the first 3 h of altitude exposure; healthy subjects, in contrast, exhibited mild diuresis, or the excretion of urine \[[@CR42]\]. The study speculated that this rapid effect is due to an early increase in the anti-diuretic hormone (ADH), which is a hormone that is responsible for water re-absorption by the kidneys. Oestrogen has been shown to lower the threshold for ADH, which causes an increase in fluid retention \[[@CR43]\]. This provides another potential mechanism explaining the results of this study.

The second mechanism relates to the concentration of erythropoietin (EPO). After exposure to high altitude, blood components associated with oxygen delivery are affected; the concentration of hemoglobin and count of red blood cells increased sharply \[[@CR44]\], which are thought to be advantageous compensations \[[@CR45]\]. Testosterone is known to be an androgen that promotes erythropoiesis, which may possibly improve oxygen carrying capacity by increasing EPO levels, conferring an advantage on men at high altitudes \[[@CR46]\]. The EPO concentration increases within hours of ascent and stimulates a gradual increase in hemoglobin for men at high altitude; at that point, the human body exhibits a hematological adaptation, reducing the prevalence of AMS. Furthermore, this is often exploited by male athletes who train at high altitude to increase the oxygen-carrying capacity of their blood to improve sea-level endurance and performance \[[@CR47]\].

However, including studied reporting LLS only may limit a large number of studies. Previous researchers have made comparisons between the ESQ-III and the LLSS, they may identify different populations as suffering from AMS \[[@CR21], [@CR48]\]. Wanger et al. \[[@CR20]\] found that the criterion of LLSS ≥3 with a headache and at least one additional symptom resulted in 63% of the climbers being diagnosed with AMS, there was a discrepancy in the diagnosis of AMS in about 16% of the cases which ESQ-III was used. Dellasanta et al. \[[@CR21]\] found that using a LLSS score of ≥3 labeled more than twice as many persons as suffering from AMS as were identified with a ESQ-III AMS criterion score of ≥0.7. Therefore, pooled studies using LLSS criterion with studies using other criterion in an analysis is not recommended.

Finally, because of time, energy and other objective constraints, the research has certain limitations. First, as mentioned in the previous paragraph, there was significant heterogeneity within this meta-analysis. The meta-regression and subgroup analysis also indicated the presence of heterogeneity, so it was difficult to avoid bias. Second, some variables within the studies used, including the race of the subjects, the number of subjects who used prophylactic drugs before the experiment and others, could not be standardized. These elements were difficult to resolve in the processing of the studies for analysis. For this reason, some of the heterogeneity may have occurred as a result of these differences among the studies. Third, the inclusion criteria were strict; for example, we selected the LLSS score as the only accepted diagnostic criterion and excluded other systems such as the ESQ-III. In addition, studies that were not prospective were also excluded. The aims of applying these criteria were to reduce the heterogeneity and improve the quality of the studies selected.

Conclusions {#Sec18}
===========

According to this study, women are more likely than men to suffer from AMS (*RR* = 1.24, 95% CI 1.09--1.41), but the conspicuous studies' heterogeneity (*I*^2^ = 66.1%, *P* = 0.000) will reduce the reliability of the conclusion. Our analysis provided a direction for future studies of the relationship of sex and the risk of AMS, such as the pathological mechanism and prevention research.

Appendix {#Sec19}
========

Table 4Critical appraisal of 18 studies on the prevalence of AMSStudy and settingSubjects (*n*)Sample designSampling frameMeasuresUnbiased assessorsResponse rate and refusersPrevalence rateScore and limitationsMurdoch et al. (1995) \[[@CR4]\] Shyangboche, Asia154GuestsMean 45.3 yearsGuests staying at hotelLake Louise consensus AMS self assessment scoring systemMicrobiologistNegative screens not assessed97.5%Refusers not described89% of famales69% of malesCI given for ORScore 5Poor sample sizeNegative screens not assessedRefusers not describedNo CI givenZiaee et al. (2003) \[[@CR9]\] Mount Damavand, Asia459TrekkersMean 31.9 yearsTrekkers around Mount Damavand in IranLake Louise consensus AMS self assessment scoring systemPediatristEpidemiologistInfectious diseases scientistNegative screens not assessed100%Refusers not described60.8% (279/459)No CI givenScore 5Negative screens not assessedRefusers not describedNo CI givenWagner et al. (2008) \[[@CR10]\] Mount Whitney, North America886HikersMean 37.6 yearsTrekkers on Mt.WhitneyLake Louise consensus AMS self assessment scoring systemSix interviewersNegative screens not assessed100%Refusers not described42.6% (337/886)No CI givenScore 5Negative screens not assessedRefusers not describedNo CI givenJafarian et al. (2008) \[[@CR27]\] Tehran, Asia90VolunteersMean 28.8 yearsIndividuals in a mountain hotel's clinicLake Louise consensus AMS self assessment scoring systemNeurologistAnesthesiologistNegative screens not assessed100%Refusers not described37.8% (34/90)CI given for subgroupScore 5Poor sample sizeNegative screens not assessedRefusers not describedMairer et al. (2009) \[[@CR22]\] Austrian Alps, Europe422Recreational hikersMean 37.4 yearsRecreational hikersLake Louise consensus AMS self assessment scoring systemMedical researcherNegative screens not assessed90%Refusers described16.6% (70/422)No CI givenScore 6Negative screens not assessedNo CI givenWu et al. (2010) \[[@CR28]\] Lhasa, Asia222PassengersMean 40.4 yearsQinghai--Tibet railroad passengersLake Louise consensus AMS self assessment scoring systemPhysiological Research Group of the Ministry of RailroadNegative screens not assessed100%Refusers not described27.0% (60/222)No CI givenScore 4Poor sample sizeNegative screens not assessedRefusers not describedNo CI givenMairer et al. (2010) \[[@CR29]\] Alps, Europe155MountaineersMean 34.7 years (group 1)Mean 36.8 years (group 2)Trekkers in both the Eastern and Western AlpsLake Louise consensus AMS self assessment scoring systemSport ScientistsMedical researchersNegative screens not assessed100%Refusers described37.4% (58/155)No CI givenScore 5Poor sample sizeNegative screens not assessedNo CI givenWang et al. (2010) \[[@CR11]\] Jade Mountain, Asia1066HikersMean 40.2 yearsTrekkers visiting Paiyun Lodge on Jade MountainLake Louise consensus AMS self assessment scoring systemHealth workersMedical researchersand doctorsNegative screens not assessed100%Refusers not described36.0% (384/1066)No CI givenScore 5Negative screens not assessedRefusers not describedNo CI givenModesti et al. (2011) \[[@CR8]\] Mount Everest Base Camp, Asia47VolunteersMean 40 yearsRecruited volunteersLake Louise consensus AMS self assessment scoring systemMedical researchers, doctorsstatisticianNegative screens assessed100%Refusers not described34.0% (16/47)No CI givenScore 5Poor sample sizeRefusers not describedNo CI givenChen et al. (2012) \[[@CR23]\] Jade Mountain, Asia787Random sampleHikersMean 42 yearsTrekkers on Jade MountainLake Louise consensus AMS self assessment scoring systemDoctors, Health ScientistsNegative screens not assessed100%Refusers not described32.8% (258/787)No CI givenScore 5Negative screens not assessedRefusers not describedNo CI givenMaclnnis et al. (2013) \[[@CR30]\] Gosainkunda,Asia491PilgrimsMean 36.7 yearsPilgrims travel to the Janai Purnima festival in Gosainkunda, Nepal (4380 m)Lake Louise consensus AMS self assessment scoring systemmedical student or internNegative screens not assessed100%Refusers not described34.0% (167/491)CI given for RRScore 6Negative screens not assessedRefusers not describedMandolesi et al. (2014) \[[@CR31]\] Mount Rosa, Europe60MountaineersMean 36.4 yearsRecruited MountaineersLake Louise consensus AMS self assessment scoring systemMedical researchersNegative screens not assessed100%Refusers not described40.0% (24/60)No CI givenScore 4Poor sample sizeNegative screens not assessedRefusers not describedNo CI givenHsu et al. (2015) \[[@CR32]\] Jiaming Lake, Asia91MountaineersMean 19.8 yearsMountaineers climbing to Jiaming Lake in TaiwanLake Louise consensus AMS self assessment scoring systemThree trained emergency physiciansNegative screens not assessed100%Refusers not described20.9% (19/91)No CI givenScore 4Poor sample sizeNegative screens not assessedRefusers not describedNo CI givenRen et al.(2015) \[[@CR33]\] Lhasa, Asia80VolunteersMean 38.4 yearsRecruited volunteersLake Louise consensus AMS self assessment scoring systemMedical researcherNegative screens not assessed100%Refusers not described43.8% (35/80)No CI givenScore 4Poor sample sizeNegative screens not assessedRefusers not describedNo CI givenHoriuchi et al. (2016) \[[@CR34]\] Mount Fuji345ClimbersMean 36.1 yearsClimbers on Mt.FujiLake Louise consensus AMS self assessment scoring systemMedical researchersNegative screens assessed88.9%Refusers not described29.5% (98/345)No CI givenScore 5Poor response rateRefusers not describedNo CI givenSánchez-Mascuñano et al. (2017) \[[@CR35]\] Spain, Europe302TravellersMean 37.7 yearsTravellers in Barcelona,SpainLake Louise consensus AMS self assessment scoring systemTrained medical doctorNegative screens not assessed92.4%Refusers described25.8% (78/302)95% CI 20.9--30.8Score 7Negative screens not assessedHoriuchi et al. (2018) \[[@CR12]\] Mount Fuji, Asia1932ClimbersMean 37.4 yearsClimbers on Mt.Fuji in JapanLake Louise consensus AMS self assessment scoring systemScientific researcherNegative screens not assessed100%Refusers not described31.6% (610/1932)CI given for subgroupScore 6Negative screens not assessedRefusers not describedJ. Boos et al. (2018) \[[@CR36]\] Himalayas, Asia80Military servicemenMean 32.1 yearsDhaulagiri region of the HimalayasLake Louise consensus AMS self assessment scoring systemAMS-C ScoresState-Trait-Anxiety-ScoreMedical researchersNegative screens not assessed100%Refusers not described47.5% (38/80)CI given for Independent predictorsScore 5Poor sample sizeNegative screens not assessedRefusers not described*AMS* acute mountain sickness, *CI* confidence interval, *RR* relative risks, *OR* odds ratios. The critical appraisal was used to estimate the quality of the published articles, determine the validity and usefulness of prospective studies and improve the overall quality of the included articles

ADH

:   Anti-diuretic hormone

AMS

:   Acute mountain sickness; 95% CI: 95% confidence interval

EPO

:   Erythropoietin

ESQ-III

:   Environmental Symptoms Questionnaire III

LLSS

:   Lake Louise Scoring System

*OR*

:   Odds ratio

*RR*

:   Relative ratio

VEGF

:   Vascular endothelial growth factor
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